Application of multi-targeted CAR-T cell therapy in B-cell acute lymphoblastic leukemia

Chimeric antigen receptor-modified T (CAR-T) cell therapy, as a new type of cellular immunotherapy, has shown good clinical efficacy in the treatment of malignant hematological tumors, especially B-cell acute lymphoblastic leukemia. However, there are problems such as antigen loss and immune evasion...

Descripción completa

Detalles Bibliográficos

Autor principal:	CAO Jinjin, DU Juan, QU Shanna, ZHU Mingyu, WANG Yang, HU Han, LIU Binlei
Formato:	Artigo
Lenguaje:	Chinês
Publicado:	Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2025-05-01
Colección:	Jichu yixue yu linchuang
Materias:	multi-target|car-t cell therapy|b-cell acute lymphoblastic leukemia|off-target effect|tumor-associated antigen
Acceso en línea:	https://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2025-45-5-675.pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!